Cenegermin Eye Drops Receive European Union Approval: The First Biotechnological Drug Resulting from Dompé Research for the Treatment of Moderate to Severe Neurotrophic Keratitis is Made in Italy
Monday, 04 September 2017
Behind the development of cenegermin are decades of Italian research, stemming from the studies of Rita Levi Montalcini, winner of the Nobel Prize in Medicine for the discovery of the nerve growth factor (NGF). In 2015, the product was designated as an orphan drug in Europe for the treatment of neurotrophic keratitis, a rare eye
- Published in Health & life sciences
No Comments